Senate Files

Bills

H.R. 2484 119th Congress

Seniors’ Access to Critical Medications Act of 2025

Latest action, Apr 29, 2025: Ordered to be Reported by the Yeas and Nays: 38 - 7.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

26 cosponsors

Sponsored by Rep. Harshbarger, Diana [R-TN-1] (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
10 D · 16 R

Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

19 clientsQ1 2025Q3 2026

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

ASSOCIATION FOR CLINICAL ONCOLOGY
7 reports
LARGE UROLOGY GROUP PRACTICE ASSOCIATION
THE MCMANUS GROUP
7 reports
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA)
AVENUE SOLUTIONS
7 reports
MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
STANTON PARK GROUP
7 reports
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
7 reports
COMMUNITY ONCOLOGY ALLIANCE
6 reports
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC
6 reports
NATIONAL ASSOCIATION OF CHAIN DRUG STORES
6 reports
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY
POWERS PYLES SUTTER & VERVILLE, P.C.
6 reports
KROGER CO
5 reports
NATIONAL ASSOCIATION OF CHAIN DRUG STORES
VAN SCOYOC ASSOCIATES
5 reports
WALGREEN COMPANY
4 reports
AMERICAN PHARMACIES, INC.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
3 reports
FOOD MARKETPLACE INC
3 reports
COLLEGE OF AMERICAN PATHOLOGISTS
2 reports
The top 25 of 27 clients, by reports
ClientLobbying firmReportsReports totalingFromToSenate
ASSOCIATION FOR CLINICAL ONCOLOGY7$1.9MQ1 2025Q3 2026yes
LARGE UROLOGY GROUP PRACTICE ASSOCIATIONTHE MCMANUS GROUP7$630KQ1 2025Q3 2026yes
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA)AVENUE SOLUTIONS7$420KQ1 2025Q3 2026yes
MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)STANTON PARK GROUP7$420KQ1 2025Q3 2026yes
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY7$5.4MQ1 2025Q3 2026yes
COMMUNITY ONCOLOGY ALLIANCE6$1.6MQ4 2025Q3 2026yes
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERNORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC6$180KQ4 2025Q3 2026yes
NATIONAL ASSOCIATION OF CHAIN DRUG STORES6$2.5MQ1 2025Q3 2026yes
NATIONAL ASSOCIATION OF SPECIALTY PHARMACYPOWERS PYLES SUTTER & VERVILLE, P.C.6$720KQ4 2025Q3 2026yes
KROGER CO5$1.9MQ1 2025Q1 2026yes
NATIONAL ASSOCIATION OF CHAIN DRUG STORESVAN SCOYOC ASSOCIATES5$60KQ1 2025Q1 2026yes
WALGREEN COMPANY4$2.8MQ1 2025Q3 2025yes
AMERICAN PHARMACIES, INC.ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)3$180KQ4 2025Q1 2026yes
FOOD MARKETPLACE INC3$960KQ1 2025Q3 2025yes
COLLEGE OF AMERICAN PATHOLOGISTS2$274KQ2 2025Q3 2025yes
HOUSE RX, INC.MARSHALL & POPP, LLC2$30KQ4 2025Q3 2025yes
HOUSE RX, INC.AVENUE SOLUTIONS2$60KQ4 2025Q3 2025yes
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION2$6.4MQ2 2025Q3 2025yes
VERTEX PHARMACEUTICALS INCORPORATEDAVENUE SOLUTIONS2$0Q1 2025Q2 2025yes
AMERICAN PHARMACY COOPERATIVE, INC.ARENTFOX SCHIFF LLP1$30KQ1 2025Q1 2025yes
AMERICANS FOR PROSPERITY1$340KQ2 2025Q2 2025yes
CENCORA FKA AMERISOURCEBERGEN CORPORATIONHORIZON GOVERNMENT AFFAIRS1$50KQ2 2025Q2 2025yes
CENCORA, INC.1$450KQ1 2025Q1 2025yes
CENTER FOR HEALTH AND DEMOCRACYPORT SIDE STRATEGIES, LLC1$20KQ3 2025Q3 2025yes
ISSUE ONE1$10KQ1 2025Q1 2025yes